Age Care Labs is one of the leading companies in the domestic care for the elderly business. Age Care Labs has raised ₹85 crore (approximately $9 million) in its fresh Series B1 funding round. It attracted a strong investor base from Zerodha-backed Rainmatter Capital, Pegasus Finvest, the Shrem Group, and a small group of family offices. The new infusion of capital is part of a $30 million (approximately $300 crore) corporate financing round scheduled to be completed in the next few months.

Fund utilization and operations infrastructure

The capital raise comes amid a series of consistent rounds of funding secured by the Gurugram-based healthcare startup. Before this most recent $9 million funding round, Age Care Labs had already raised over $20 million in capital. This historical total also covers a substantial $11 million pre-Series B round, again concluded in late 2023, and also anchored by Rainmatter Capital with Gruhas. 

The successful closure of the new tranche will reflect ongoing investor appetite for the platforms addressing a fragmented elder care market within India’s intricate system. The operational scope provided in the official press release outlines how Age Care Labs will progressively utilize the $9 million to advance its daily operations, scale its technology strength, expand its specialized service suites, and drive the next step in geographic growth throughout the country. 

The business benefits from a highly specialized asset-light approach, enabling it to expand seamlessly across target segments. There is a seamless integration of leased operational properties and strong partnerships with maintenance operators, which allows the company to gradually enter a new region without putting significant capital expenditure on its balance sheet.

The platform has two operational sub-brands, Emoha and Epoch Elder Care, which support the platform’s comprehensive senior care portfolio. These two organisations offer a vast network reaching more than 60,000 senior citizens in 120 cities in India. The company has established itself robustly in the major metros, but the flexibility of its asset-light service delivery platform assists in its effective expansion into Tier-I and Tier-II cities to bridge both clinical and at-home monitoring gaps across regional markets.

Business architecture and focus

The business model of Age Care Labs positions its main services to deliver support within targeted elder care segments, for delivering the service in their home and also for delivering their specific nursing services. Its initial brand is Emoha, a home and application-based elder care platform. 

Emoha delivers all essential day-to-day support needed for independent seniors with the services of an emergency medical response, around-the-clock monitoring, remote telemedicine consultation, interactive engagement platforms, and tailored wellness programs for the aged population, designed to benefit their daily living at home safely and securely. Epoch Elder Care’s second arm, Epoch Operations, focuses on the clinical needs of high-demand facilities directly managed by them, including professional dementia care homes and assisted living facilities. 

Epoch is really all about offering high-touch, long-term nursing care to those who are experiencing cognitive difficulties or serious health issues. Age Care Labs is aggressively expanding this niche healthcare sector through rollout in new markets by investing in franchise partnerships, corporate acquisitions, and institutional agreements, which will help build a solid expansion pipeline of care homes in diverse locations.

Conclusion

Age Care Labs’ ability to secure the $9 million funding round is a testament to the growing market maturity and positive investor sentiment for organized health platforms tailored specifically for the needs of seniors. The company has successfully shaped a scalable solution in a fragmentarily structured sector by combining app-based monitoring instruments from Emoha with asset-light care homes from Epoch Elder Care.

With continued backing from institutional investors such as Rainmatter, Pegasus Finvest, and the Shrem Group, the firm is poised to progress toward achieving its expanded goals of raising ₹250 crore.